Publisher
Springer Berlin Heidelberg
Reference50 articles.
1. Agence Francaise de Securite Sanitaire des Produits de Sante (2001): Reevaluation du service medical rendu de 4500 specialites pharmaceutiques. 07.06.2001.
http://www.agmed.sante.gouv.fr
.
2. Agodoa L.Y., Appel L., Bakris G.L., Beck G., Bourgoignie J., Briggs J.P. et al. for the African American Study of Kidney Disease and Hypertension (AASK) Study Group (2001): Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis. A randomized controlled trial. JAMA 285: 2719–2728.
3. Barbui C., Hotopf M. (2001): Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials. Br. J. Psychiatry 178: 129–144.
4. Bazell R.J: (1971): Drug efficacy study: FDA yields on fixed combinations. Science 172: 1013–1015.
5. Beermann B., Till A.E., Gomez H.J., Hochens M., Bolognese J.A., Junggren I. (1989): Pharmacokinetics of lisinopril (IV/PO) in healthy volunteers. Biopharm. Drug Dispos. 10: 397–409.